Annotation Detail for PFAS
Basic Information
Top
Pathway ID | Pathway Name |
---|
PWY-841 | purine nucleotides de novo biosynthesis II |
PWY-6121 | 5-aminoimidazole ribonucleotide biosynthesis I |
Pathway ID | Pathway Name |
---|
P02738 | De novo purine biosynthesis |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of PFAS mRNA | decreases expression | 20064835
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of PFAS mRNA | affects cotreatment|decreases expression | 17404688
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of PFAS mRNA | affects cotreatment|decreases expression | 17404688
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.57 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.57 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.88 | 6695378 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.73 | 19183758 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
6.20 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.91 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.89 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.89 | 17289903 18497071 17261762 16675129 14630087 17018787 12948864 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.89 | 17614352 16175315 15562024 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
5.21 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.79 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.14 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
3.06 | 18566989 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.83 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
5.15 | 17187935 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.36 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.25 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
4.21 | 16134523 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.09 | 16530937 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.85 | 20471113 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.90 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.62 | 17088409 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
5.05 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.79 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.23 | 16627594 16393666 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.80 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.36 | 15610895 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.69 | 14659978 14716833 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
2.17 | 21137059 20195826 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.57 | 18569708 17053015 18816296 18520028 20464547 20135361 6695378 20064080 20869020 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.95 | 11408345 11807958 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.95 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.35 | 19453300 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.53 | 16381670 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.62 | 16810080 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.35 | 11141357 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.47 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
4.23 | 16427766 11399458 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.23 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
5.23 | 16525653 17393432 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.37 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.02 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.02 | 16740699 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.97 | 18045962 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.54 | 10029692 19755658 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
5.02 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.55 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.31 | 17053015 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00130 |
- |
L-Glutamine |
Dietary supplement;Micronutrient;Non-Essential Amino Acids |
DB00142 |
- |
L-Glutamic Acid |
Dietary supplement;Micronutrient;Non-Essential Amino Acids |